Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Diagnostic utility of 18F-Fluorodeoxyglucose positron emission tomography (FDG-PET) in asymptomatic subjects at increased risk for Alzheimer's disease.

European journal of nuclear medicine and molecular imaging - 1 Jul 2018

Drzezga Alexander, Altomare Daniele, Festari Cristina, Arbizu Javier, Orini Stefania, Herholz Karl, Nestor Peter, Agosta Federica, Bouwman Femke, Nobili Flavio, Walker Zuzana, Frisoni Giovanni Battista, Boccardi Marina

Abstract excerpt

PURPOSE: To assess the clinical utility of 18F-Fluorodeoxyglucose positron emission tomography (FDG-PET) for detection of early signs of neurodegeneration in conditions of increased risk for Alzheimer's disease (AD) as defined by: subjective cognitive decline (SCD), evidence of cerebral amyloid-pathology, apolipoprotein E (APOE) ε4-positive genotype, or autosomal dominant forms of AD (ADAD) in asymptomatic...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Alzheimer Disease
Share to Apolipoproteins E

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Fluorodeoxyglucose F18

Share to SCD gene

Share to Genetic Predisposition to Disease

Share to Positron-Emission Tomography

Share to Radiopharmaceuticals

Source

Identifiers

PMID: 29756163
DOI: 10.1007/s00259-018-4032-1

Genes

APOE
SCD

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Diagnostic utility of 18F-Fluorodeoxyglucose positron emission tomography (FDG-PET) in asymptomatic subjects at increased risk for Alzheimer's disease.PMID 29756163Read ↗

Clinical diagnosis of Alzheimer's disease: recommendations of the International Working Group.Semantic proximity Read ↗

Advancing research diagnostic criteria for Alzheimer's disease: the IWG-2 criteria.Semantic proximity Read ↗

Early detection of Alzheimer's disease using neuroimaging.Semantic proximity Read ↗

Evaluation and use of diagnostic tests in Alzheimer's disease.Semantic proximity Read ↗

From clinical phenotype to proteinopathy: molecular neuroimaging in neurodegenerative dementias.Semantic proximity Read ↗

Amyloid burden and metabolic function in early-onset Alzheimer's disease: parietal lobe involvement.Semantic proximity Read ↗

Prevalence of amyloid PET positivity in dementia syndromes: a meta-analysis.Semantic proximity Read ↗

Differential diagnosis of neurodegenerative dementias using metabolic phenotypes on F-18 FDG PET/CT.Semantic proximity Read ↗

Considerations regarding a diagnosis of Alzheimer’s Disease before dementia: a systematic reviewSemantic proximity Read ↗

Red flags for remote cognitive assessment: An expert consensus study using the Delphi method on behalf of the Canadian Consortium on Neurodegeneration in AgingSemantic proximity Read ↗

Age- and Brain Region-Specific Changes of Glucose Metabolic Disorder, Learning, and Memory Dysfunction in Early Alzheimer's Disease Assessed in APP/PS1 Transgenic Mice Using 18F-FDG-PET.Semantic proximity Read ↗

Neuroimaging for diagnosis of dementia.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.